Sign in Subscribe
Universities and colleges

High-Throughput Elucidation of Synthetic Genetic Interactions Reveals New Pathways for Cancer Treatment

Strategic Insights

— 1 min read

Researchers from the University of California have developed a powerful new approach to identify compounds that target specific pathways in cancer cells, using a network of synthetic genetic interactions (SGIs) to predict genetic robustness and fault-tolerance in the genome. By analyzing the SGI network, the researchers identified a compound called 1A08, which selectively inhibits DNA damage checkpoint signaling in yeast cells and causes DNA-damage resistant DNA synthesis in human colorectal cancer cells. This breakthrough has significant implications for cancer treatment, as it highlights the potential of SGIs to reveal new pathways for targeted therapy.

Key Takeaways:

  • The synthetic genetic interaction (SGI) network can be used to predict genetic robustness and fault-tolerance in the genome, enabling the identification of compounds that target specific pathways.
  • The researchers used the SGI network to predict the genetic interactions of various compounds and identified 1A08 as a potent inhibitor of DNA damage checkpoint signaling.
  • 1A08 was found to cause DNA-damage resistant DNA synthesis in human colorectal cancer cells, suggesting its potential as a therapeutic agent.
  • The SGI network approach can be used to identify new pathways for cancer treatment and improve the effectiveness of existing therapies.
  • The study highlights the potential of genomics and synthetic biology to reveal new insights into cancer biology and develop novel therapeutic strategies.
  • The researchers demonstrated the utility of the SGI network for pathway-to-drug discovery, using the DNA damage checkpoint as the target pathway.
  • The study provides a new perspective on the development of targeted cancer therapies, emphasizing the importance of understanding the genetic interactions between cancer cells and their environment.

Statistics:

  • 15 compounds out of 3100 screened showed selective toxicity toward the sod1 Delta strain relative to the isogenic wild-type strain.
  • The compound 1A08 inhibited DNA checkpoint signaling in yeast cells.
  • The study demonstrated 1A08-induced DNA-damage resistant DNA synthesis in human HCT-116 colorectal cancer cells.
  • 1A08 caused a transient increase in growth in the presence of sublethal doses of DNA damaging agents in yeast cells.
  • The SGI network contained 2019-2030 synthetic genetic interactions, as reported in the study.

Sources:

  • Tamble, C.M., et al. (2011). The synthetic genetic interaction network reveals small molecules that target specific pathways in Sacchromyces cerevisiae. Molecular Biosystems, 7(6), 2019-2030.
  • University of California, Department of Biomolecular Engineering
  • Gene Therapy Weekly editors, and staff reports (2011)
  • Cancer Gene Therapy
  • Royal Society Chemistry (Publisher of Molecular Biosystems)

Read more